CN104357550B - A kind of syndromic diagnostic product of Axenfeld-Rieger that detects - Google Patents

A kind of syndromic diagnostic product of Axenfeld-Rieger that detects Download PDF

Info

Publication number
CN104357550B
CN104357550B CN201410515439.8A CN201410515439A CN104357550B CN 104357550 B CN104357550 B CN 104357550B CN 201410515439 A CN201410515439 A CN 201410515439A CN 104357550 B CN104357550 B CN 104357550B
Authority
CN
China
Prior art keywords
mmrn1
axenfeld
gene
rieger
syndromic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410515439.8A
Other languages
Chinese (zh)
Other versions
CN104357550A (en
Inventor
陈鹏
谢立信
孙大鹏
李素霞
张阳阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SPECIALTY OF OPHTHALMOLOGY RESEARCH INSTITUTE SHANDONG PROV
Original Assignee
SPECIALTY OF OPHTHALMOLOGY RESEARCH INSTITUTE SHANDONG PROV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SPECIALTY OF OPHTHALMOLOGY RESEARCH INSTITUTE SHANDONG PROV filed Critical SPECIALTY OF OPHTHALMOLOGY RESEARCH INSTITUTE SHANDONG PROV
Priority to CN201410515439.8A priority Critical patent/CN104357550B/en
Publication of CN104357550A publication Critical patent/CN104357550A/en
Application granted granted Critical
Publication of CN104357550B publication Critical patent/CN104357550B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The object of this invention is to provide a kind of MMRN1 gene and detect the application in Axenfeld-Rieger syndrome diagnosis goods in preparation, the invention provides the new purposes of MMRN1 gene, thereby a kind of approach that effectively carries out the diagnosis of congenital Axenfeld-Rieger syndrome disease gene, antenatal gene screening and genetic counselling is provided, and effect shows the SNP site of gene provided by the present invention and detects primer and can be effectively carry out the fast detecting of MMRN1 gene mutation site for clinical patients and fetus fine hair or amniotic fluid.

Description

A kind of syndromic diagnostic product of Axenfeld-Rieger that detects
Technical field
The invention belongs to gene diagnosis goods preparing technical field, be specifically related to a kind of detectionThe syndromic diagnostic product of Axenfeld-Rieger.
Background of invention
Axenfeld-Rieger syndrome refers to eyes developmental defect, with or grow without whole bodyOne group of abnormal developmental character disease, is characterized in: eyes developmental defect; Can be with whole body dysplasia;Secondary glaucoma; Autosomal dominant inheritance, has family history more, also has the report of Sporadic cases;Men and women falls ill identical. There is no at present effective treatment measure, operation poor prognosis.
The syndromic clinical characters of Axenfeld-Rieger is: the 1. existence of posterior embryotoxon: be thisSick characteristic feature, it shows as thickening of Schwalbe line and gives prominence to and reach. 2. iridocorneal angle is differentNormal: its main feature is that the thick band of organizing is crossed over angle recess from peripheral iris, with outstandingSchwalbe line is connected and angle, room is open, but iris root adheres to a high position, sclera ridge often byCover, iris root invests after trabecular network. 3. iris is abnormal: main manifestations is iris attenuation, mistakeGo that normal texture, pigment epithelial layer turn up, coremetamorphosis multiple pupil and occlusion of pupil etc. 4. can be withWhole body is abnormal: be mainly tooth and facial developmental defect; As tooth defect denticle, anodontia; Face middle partFlat, maxillary development can not have other whole bodies abnormal entirely in addition. 5. secondary glaucoma: 50%Above patient has secondary glaucoma, with childhood and adolescence morbidity common, but also have baby childrenYoungster's phase or midlife are sent out patient. 6. eyes morbidity: the overwhelming majority is eyes morbidities, is simple eye extremely individuallyMorbidity. 7. asexuality difference. 8. this disease has family history.
The syndromic etiology and pathology of Axenfeld-Rieger it be unclear that, and studies in the world at present less.Genetics research result both domestic and external shows that this disease mostly is autosomal dominant inheritance, also has Sporadic casesReport. Up to now, scientists has been located 3 Axenfeld-Rieger syndrome diseasesThe site of gene, and cloned 2 Disease-causing genes (referring to table 1).
Table 1:Axenfeld-Rieger syndrome Disease-causing gene location and clone's situation
Disease-causing gene Chromosome mapping
PITX2 4q25
FOXC1 6p25.3
13q14
But known only can be explained a fraction of patient's morbidity, and this becomesThe syndromic pathogenetic research of Axenfeld-Rieger and etiotropic diagnosis and treatment researchBottleneck. This present situation impel further go find and understand the Disease-causing gene that this disease is new, for follow-upGene diagnosis, pre-natal diagnosis and gene therapy provide basis.
Summary of the invention
The object of this invention is to provide the syndromic diagnostic product of a kind of Axenfeld-Rieger of detection,Detect Axenfeld-Rieger syndrome from polyprotein 1 (MMRN1) design molecular labeling,Thereby make up the deficiencies in the prior art.
Applicant is the Axenfeld-Rieger syndrome family of autosomal dominant inheritance from 4 generationsIn, the whole members of this family have been carried out to full genome linkage analysis, determine the polyprotein 1 of this family(MMRN1) there is the pathogenic mutation in heredity, and in follow-up work, verified MMRN1 withThe syndromic relation of Axenfeld-Rieger, thus the present invention facilitated.
First the present invention provides the purposes that MMRN1 gene is new, for the preparation of detectionApplication in Axenfeld-Rieger syndrome diagnosis goods;
Above-mentioned diagnostic product, as embodiment preferably, be to detect Axenfeld-Rieger syndromePrimer or probe.
It is a kind of for detection of the syndromic primer pair of Axenfeld-Rieger, described that the present invention also providesThe upstream and downstream primer sequence of primer pair is in SEQIDNO:1-24, and its primer information is as follows:
The present invention also provides a kind ofMMRN1 gene code region is played the 1952nd by initiation codon, and its base is C or A;
Wherein as follows for detection of the primer information in above-mentioned SNP site:
MMRN1-E6-2F:GCTTTTATCAACTGAACAGGSEQIDNO:13
MMRN1-E6-2R:TTCCATATCGGAGGTACATTSEQIDNO:14。
The present invention also provides the SNP position of another and Axenfeld-Rieger syndrome disease associationPoint plays the 1157th for MMRN1 gene code region by initiation codon, and its base is T or A;
Wherein as follows for detection of the primer information in above-mentioned SNP site:
MMRN1-E6-1F:TGTTCTGCAAGTGATATCTCSEQIDNO:11
MMRN1-E6-1R:GTACTCAGTGACATTATTGCSEQIDNO:12
It is a kind of for detection of the syndromic kit of Axenfeld-Rieger that the present invention also provides, and includesAny one or several in above-mentioned primer pair.
The invention provides the new purposes of MMRN1 gene, effectively carry out thereby provide a kind ofThe approach of the diagnosis of Axenfeld-Rieger syndrome disease gene, antenatal gene screening and genetic counselling,Effect show the SNP site of gene provided by the present invention and detect primer can be effectively forClinical patients and fetus fine hair or amniotic fluid carry out MMRN1 gene mutation site fast detecting.
Brief description of the drawings
Patient and normal person MMRN1 in the Axenfeld-Rieger syndrome family of Fig. 1: embodiment 1Sequencer map, wherein A: patient; B: normal person in family. Five patient MMRN1 bases in this familyBecause coding region plays the 1952nd by initiation codon, heterozygous mutant has occurred, its base is prominent by CBecome A.
The Axenfeld-Rieger syndrome patient of Fig. 2: embodiment 2 and mother MMRN1 order-checking thereofFigure, wherein A: patient; B: mother. This patient MMRN1 gene code region is by initiation codonRise the 1157th there is heterozygous mutant, its base by T for sporting A.
Detailed description of the invention
MMRN1 gene is positioned at Chr4:90.8 – 90.88Mb, the about 3687bp's of transcribed one-tenthMRNA (NCBI accession number is NM_007351.2), directly translation forms 1228 amino acid groupsThe protein becoming.
Below in conjunction with embodiment, the present invention is described in detail.
Embodiment 1: the sudden change of screening MMRN1 gene from Axenfeld-Rieger syndrome familySite
1, extract peripheral blood genomic DNA:
Meet national relevant policies regulation, and on the basis of agreeing at sampling object, extracting firstThe peripheric venous blood 2-5ml of Axenfeld-Rieger syndrome family member, puts into EDTA anticoagulant tube,-80 DEG C frozen for subsequent use; Frozen EDTA anticoagulation, after room temperature is melted, is got 500 μ L and is put in centrifugalPipe, adds equal-volume TE (pH8.0), mixes, and 4 DEG C, centrifugal 10 minutes of 10000rpm, abandonsClearly.
Add 180 μ LTE, 20 μ LSDS (10%), 8 μ L Proteinase Ks (l0mg/ml) to mix, putSpend the night in 37 DEG C of water-baths. From water-bath, take out sample, instantaneous centrifugation sample. In reaction tube, addEnter the saturated phenol of isopyknic Tris-(approximately 300 μ L), fully mix, 10000rpm centrifugal 10 under room temperatureMinute, draw supernatant (approximately 300 μ L) to a new centrifuge tube. Repeat phenol extracting once, in absorptionIn the new centrifuge tube of clear liquid to.
Add the saturated phenol of isopyknic Tris: chloroform mixed liquor (phenol, the each 150 μ L of chloroform), mixes chamberCentrifugal 10 minutes of temperature 10000rpm, shifts the new centrifuge tube of supernatant to.
Add the saturated phenol of isopyknic Tris: chloroform: isoamyl alcohol mixed liquor (phenol, chloroform, isoamyl alcohol each 100μ L), mix, centrifugal 10 minutes of room temperature 10000rpm, shifts the new centrifuge tube of supernatant to.
Add l/10 volume 3mol/L, pH5.2 sodium acetate (approximately 30 μ L), 2 times of volume precoolings 100%Ethanol, mixes visible white flocculent deposit gently. Centrifugal 10 minutes of room temperature 10000rpm, makesDNA is deposited in the pipe end, abandons supernatant.
Add 70% ethanol to DNA precipitation, rinsing once, centrifugal 5 minutes of room temperature 7000rpm,Abandon supernatant, be placed in room temperature volatilization residue ethanol, finally add 50 μ LTE (pH8.0), 4 DEG C are spent the nightDissolving DNA.
To the capable agarose gel electrophoresis of DNA extracting, and apply ultraviolet specrophotometer at 260nm and280nm colorimetric, detects DNA purity and concentration.
2, linkage analysis: passed through by logical Deco skill Development Co., Ltd of the happy U.S. in BeijingOmniZhonghua8 chip carries out linkage analysis to member in this family, shows the region that possibility is chainFor: Chr1:32048052-41842350, Chr4:83673890-133385086, Chr5:148196737-158687153,Chr10:135656-13166875,Chr13:46707064-60101738,Chr15:64367745-78960529,Chr16:23361853-27126459,Chr19:288738-3013374。
3, extron group order-checking: extron group order-checking (ExomeSequencing) is a kind of novelGenome analysis technology, only need, for the DNA in full gene extron (exon) region, get this family3 patients' genomic DNA in system, applies with health Bioisystech Co., Ltd by Beijing shellfish is auspiciousAgilentHumanAllExon50M chip is caught the exon region of human genome, then rightHigh-flux sequence is carried out in the extron library of enrichment. To suddenly change and filter 4 data of normal people storehouses: monokaryonThuja acid polymorphism data storehouse (ftp: //ftp.ncbi.nih.gov/snp/database/), thousand human genome plans(ftp: //ftp-trace.ncbi.nih.gov/1000genomes/ftp/), Hapmap8 database(http://hapmap.ncbi.nlm.nih.gov/), and Yan Di and Huang Di, two legendary rulers of remote antiquity's database(http://yh.genomics.org.cn/), further filters out 3 patients have be positioned at and may connect40, the nonsynonymous mutation site in lock region, application direct sequencing screens and causes a disease in this familyHaplotype be divided into from Disease-causing gene MMRN1, and at normal population peripheral blood genomic DNA sampleIn this, carry out the Mutation Screening in this site, do not find this sudden change.
4, direct sequencing is verified the sudden change of patient MMRN1 gene in this family
Pcr amplification object fragment: reaction condition and reaction system:
(1) PCR reaction condition: 94 DEG C of 3min; 94 DEG C of 40sec, 55 ± 3 DEG C of 40se, 72 DEG C60sec,30-35cycles;72℃10min。
(2) reaction system: (TAKARALATaqpolymerase)
Applying this reaction system carries out respectively the genomic DNA template of Mei Ming family member and is somebody's turn to doThe amplified reaction of MMRN1 primer.
The order-checking of PCR product: apply conventional Sanger PCR sequencing PCR above-mentioned PCR product is checked order,Wherein apply primer pair MMRN1-E6-2F:GCTTTTATCAACTGAACAGG,MMRN1-E6-2R:TTCCATATCGGAGGTACATT, five patients in this familyMMRN1 gene code region is played the 1952nd by initiation codon heterozygous mutant, its base has been occurredBy C for sporting A (Fig. 1). Repeatedly sequencing result shows that this mutational site is not because amplificationOr the wrong introduction of order-checking. Point of application mutation forecasting program SIFT and all discoveries of PolyPhen prediction,This sudden change has caused the damage of MMRN1 protein function " damaging " level, thereby has caused patientThe syndromic generation of Axenfeld-Rieger. And it is normal in the 200 normal local crowds of example and this familyIn people's peripheral blood genomic DNA sample, carry out the Mutation Screening in this site, do not find this sudden change.
By above-mentioned analysis, prove that MMRN1 gene can be used for detecting patient and whether have latentSuffering from the syndromic danger of Axenfeld-Rieger. Each by by tester's MMRN1 geneExtron fragment, in normal homologous segment comparison, is determined person's to be detected ill risk.
According to the primer pair of its each extron of genome sequence design amplification of MMRN1, its positive and negative drawingThe sequence information of thing is as follows:
MMRN1-E1F:AGAAACAGGAAACCGAACTT
MMRN1-E1R:ATAATTTTCTGGGAGTGAGG
MMRN1-E2F:GCAATCTTACAAGGTTTCTG
MMRN1-E2R:GTGTCTGCATTTTCACTTAC
MMRN1-E3F:TAGGCATTGCCCCAAAAACT
MMRN1-E3R:TAACAGTCCTAGGAGTTTGGC
MMRN1-E4F:GCTTCAGTACGCGGGAAAATG
MMRN1-E4R:CCACAATTTCTCCCAACATCC
MMRN1-E5F:TAGTGGTGAAAGTGAGCATC
MMRN1-E5R:CATACCACCCAAACTAAAGC
MMRN1-E6-1F:TGTTCTGCAAGTGATATCTC
MMRN1-E6-1R:GTACTCAGTGACATTATTGC
MMRN1-E6-2F:GCTTTTATCAACTGAACAGG
MMRN1-E6-2R:TTCCATATCGGAGGTACATT
MMRN1-E6-3F:ACTATGCCCTAAAAGAGACT
MMRN1-E6-3R:TTGCTCAACTGTACAGATCT
MMRN1-E7F:CTAAGGGATTTGCATGACGT
MMRN1-E7R:AGTGGATCCAGATTAAGCAG
MMRN1-E8-1F:TGCTAAGTTTGATGGATGGC
MMRN1-E8-1R:CACTTTGTTTTCTGTGCCAC
MMRN1-E8-2F:CTGCTCTGTTTTGGTTTTTC
MMRN1-E8-2R:GAGCATCCCATAAATTGTAG
MMRN1-E8-3F:GTACCTACAGATCTGCCCTT
MMRN1-E8-3R:GTGCTTCTGATTCTCATGGG
Apply respectively above-mentioned every pair of primers and carry out the detection of MMRN1 gene.
Embodiment 2: screen MMRN1 base in the congenital Axenfeld-Rieger of distributing syndrome patientThe mutational site of cause
Axenfeld-Rieger syndrome patient is distributed in collection: in Shandong eye institute and Qingdao eyeHospital of section collects the clear and definite Axenfeld-Rieger syndrome of diagnosis and distributes patient.
Extract peripheral blood genomic DNA:
Extract respectively the peripheric venous blood that this distributes Axenfeld-Rieger syndrome patient and mother thereof2-5ml, puts into EDTA anticoagulant tube, and-80 DEG C frozen for subsequent use; Frozen EDTA anticoagulation is in chamberTemperature melt after, get 500 μ L and be put in centrifuge tube, the conventional phenol chloroform method of narrating in Application Example 1 fromIn family, in each member's peripheral blood, extract genomic DNA.
Pcr amplification object fragment: reaction condition and reaction system:
(1) PCR reaction condition: 94 DEG C of 3min; 94 DEG C of 40sec, 55 ± 3 DEG C of 40se, 72 DEG C of 60sec,30-35cycles;72℃10min。
(2) reaction system: (TAKARALATaqpolymerase)
Apply genomic DNA template that this reaction system carries out respectively every patient respectively withThe amplified reaction of 12 pairs of primers of MMRN1 gene.
PCR product order-checking: apply the genomic DNA mould of conventional Sanger PCR sequencing PCR to this patientPlate checks order with the amplified production of 12 pairs of primers of MMRN1 gene respectively, wherein uses primer pairMMRN1-E6-1F:TGTTCTGCAAGTGATATCTC and MMRN1-E6-1R:GTACTCAGTGACATTATTGC has detected MMRN1 gene in this name is distributed patientHeterozygous mutant: MMRN1 gene code region is played the 1157th base by initiation codon and has been occurredHeterozygous mutant, sports A (Fig. 2) by T, causes that the 386th, MMRN1 albumen dashed forward by leucineBecome glutamine, point of application mutation forecasting program SIFT predicts discovery, and this sudden change has caused MMRN1The damage of protein function " damaging " level, thus patient Axenfeld-Rieger syndrome causedGeneration. And in 200 example normal local crowds and this familys normal person's peripheral blood genomic DNAIn sample, carry out the Mutation Screening in this site, do not find this sudden change. Thereby show the prominent of MMRN1 geneBecome with Axenfeld-Rieger syndrome and have linkage relationship.

Claims (4)

1. a MMRN1 gene is in for the preparation of detection Axenfeld-Rieger syndrome diagnosis goodsApplication, it is characterized in that, described detection for detect MMRN1 gene code region whether exist by riseBeginning codon plays the base C of the 1952nd to the sudden change of A; Or played the alkali of the 1157th by initiation codonBase T is to the sudden change of A.
2. application as claimed in claim 1, is characterized in that, described diagnostic product is that PCR detectsPrimer or probe.
3. for detection of the syndromic primer pair of Axenfeld-Rieger, it is characterized in that, describedPrimer pair be MMRN1-E6-1F:TGTTCTGCAAGTGATATCTCSEQIDNO:11,MMRN1-E6-1R:GTACTCAGTGACATTATTGCSEQIDNO:12 orMMRN1-E6-2F:GCTTTTATCAACTGAACAGGSEQIDNO:13、MMRN1-E6-2R:TTCCATATCGGAGGTACATTSEQIDNO:14。
4. for detection of the syndromic kit of Axenfeld-Rieger, it is characterized in that described examinationAgent box includes any one or several in primer pair claimed in claim 3.
CN201410515439.8A 2014-09-30 2014-09-30 A kind of syndromic diagnostic product of Axenfeld-Rieger that detects Active CN104357550B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410515439.8A CN104357550B (en) 2014-09-30 2014-09-30 A kind of syndromic diagnostic product of Axenfeld-Rieger that detects

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410515439.8A CN104357550B (en) 2014-09-30 2014-09-30 A kind of syndromic diagnostic product of Axenfeld-Rieger that detects

Publications (2)

Publication Number Publication Date
CN104357550A CN104357550A (en) 2015-02-18
CN104357550B true CN104357550B (en) 2016-05-25

Family

ID=52524856

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410515439.8A Active CN104357550B (en) 2014-09-30 2014-09-30 A kind of syndromic diagnostic product of Axenfeld-Rieger that detects

Country Status (1)

Country Link
CN (1) CN104357550B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103571847B (en) * 2012-07-26 2017-08-25 汕头大学·香港中文大学联合汕头国际眼科中心 FOXC1 gene mutation bodies and its application

Also Published As

Publication number Publication date
CN104357550A (en) 2015-02-18

Similar Documents

Publication Publication Date Title
Burnside 22q11. 21 deletion syndromes: a review of proximal, central, and distal deletions and their associated features
Sanna-Cherchi et al. Exome-wide association study identifies GREB1L mutations in congenital kidney malformations
Morrison et al. National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology
Li et al. Spectrum of variants in 389 Chinese probands with familial exudative vitreoretinopathy
Singh et al. Chromosomal abnormalities and epilepsy: a review for clinicians and gene hunters
Davidson et al. Brittle cornea syndrome ZNF469 mutation carrier phenotype and segregation analysis of rare ZNF469 variants in familial keratoconus
CN104561016A (en) CC (congenital cataract) PITX3 gene novel mutation
Farzadfard et al. Screening for MIR184 mutations in Iranian patients with keratoconus
Zhu et al. Diagnosis for choroideremia in a large Chinese pedigree by next‑generation sequencing (NGS) and non‑invasive prenatal testing (NIPT)
Fan et al. The mutation spectrum in familial versus sporadic congenital cataract based on next-generation sequencing
Gal et al. Novel mutation in TSPAN12 leads to autosomal recessive inheritance of congenital vitreoretinal disease with intra‐familial phenotypic variability
CN106834287A (en) A kind of SNP marker for detecting RhD negative phenotypes
CN105256059B (en) TUBA3D gene is preparing the application in keratoconus diagnostic product
CN103589787B (en) The application of ABCA3 gene in the congenital CCMC diagnostic product of preparation
Zhang et al. Heterogeneity of Axenfeld–Rieger Syndrome: Molecular and Clinical Findings in Chinese Patients
CN106282383B (en) Application of the KRT12 gene in detection keratoconus
CN107312859A (en) Application of the AQP5 genes in detection congenital cataract product is prepared
CN104357550B (en) A kind of syndromic diagnostic product of Axenfeld-Rieger that detects
CN105274225B (en) It is a kind of for detecting the SNP site of patch shape corneal dystrophy disease
CN106967808A (en) A kind of primer sets and its application for being used to detect RhD negative blood groups
CN103820548B (en) Application of MYO18A gene in preparation of diagnostic product for treating congenital microphthalmia
CN106399564A (en) Application of ERCC8 (excision repair cross complementary group 8) gene to congenital cataract combined keratoconus detection
Ha et al. Mutation analysis of the carbohydrate sulfotransferase gene in Vietnamese with macular corneal dystrophy
CN105803078B (en) CRYBA4 gene is detecting the application in congenital CCMC
CN104357551B (en) TMCO3 gene detects the application in Fuchs Fuch's dystrophy goods in preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant